Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
SAB Biotherapeutics Inc
SABS
Healthcare
Biotechnology
SAB Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of human polyclonal immunotherapeutic antibodies, or human immunoglobulin G (hIgG), to address immunology disorders. The Company is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel...
targets or best-in-class against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders. The Company’s lead product candidate, SAB-142, is a human anti-thymocyte globulin (ATG) focused on preventing or delaying the progression of T1D. SAB-142 is expected to reduce autoimmune beta cell destruction and delay progression or onset of T1D in patients with Stage III or Stage II T1D. The Company’s genetic engineering platform produces human, multi-targeted, high-potency immunoglobulins, without the need for human donors or convalescent plasma.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:SABS)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on Aug 07, 2025 7:30am
New Press Release - SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
Recently raised $175 million in oversubscribed private placement which included strategic investor Sanofi and top-tier biotech investorsStrong cash position with completed financing extending operational runway until the middle of 2028 Achieved alignment with FDA on the design and advancement of...
read article.
(1)
•••
UnknownUnknowns
X
Comment by
UnknownUnknowns
on Jul 23, 2025 12:32pm
RE:SABS....trading at $3.40 now
Looked at my stock ticker yesterday morning. Stock at over $5 but dropping. Managed to sell for $4.32. Dropped that much in just the minute or so it took to sign into my account. Had bought for $1.80
...more
(475)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 21, 2025 8:47am
SABS....trading at $3.40 now
Did somebody say FOMO????
(475)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 21, 2025 8:15am
RE:SABS....1st scalp of the a.m on the NR
SABS is buying me lunch today. Cheers !!!! No FOMO for this Cowboy
(242)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jul 21, 2025 8:03am
Buy buddy buy because it's taking off this morning.
Otherwise FOMO for you fellas out there today anyway so good luck to all of you guys
(475)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 21, 2025 7:54am
SABS....1st scalp of the a.m on the NR
Lunch money works for me ; )
(3)
•••
dragshot
X
Post by
dragshot
on Jun 01, 2023 6:46am
Sheesh!
Where is everybody? People should be discussing this one. Technicals are lining up nicely. Just waiting for my trigger point. GL... where ever you are.
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Eshbal Signs Definitive Agreement to Acquire Majority Interest in NYC-Based Dare to Be Different Foods
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha